TRACY CLASON: Open Payments
NPI 1003991209 · VANCOUVER, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$875 in 45 payments from 10 companies in 2025. Trend: 2023 $436 · 2024 $825 · 2025 $875
Food & beverage: $875
| Company | Payments | Amount |
|---|---|---|
| Bausch Health US, LLC | 12 | $220 |
| ABBVIE INC. | 14 | $214 |
| Axsome Therapeutics, Inc. | 4 | $113 |
| Neurocrine BioSciences, Inc. | 3 | $81 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $63 |
| Alkermes, Inc. | 2 | $58 |
| Supernus Pharmaceuticals, Inc. | 3 | $48 |
| Vanda Pharmaceuticals Inc. | 1 | $30 |
| Lundbeck LLC | 2 | $27 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
Products named: APLENZIN, VRAYLAR, Auvelity, INGREZZA, TRINTELLIX, ARISTADA, Qelbree, FANAPT.
Industry payments across WA — which companies pay providers there.
